<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-IND-T-WJCF</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Joint Effort for Elimination of TB (JEET 2.0), India</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">India - Tuberculosis - William J. Clinton Foundation - WJCF.  This program has the following goals: To achieve a rapid decline in burden of TB, morbidity and mortality to achieve the Sustainable Development Goals of 80% reduction in incidence and 90% reduction in deaths by 2025; five years earlier than the stipulated timeline.. The objectives of this program are: Build, strengthen and sustain enabling policies, empowered institutions, multi-sectoral collaborations, engaged communities, and human resources with enhanced capacities to create a supportive ecosystem to END TB..  Prevent the emergence of TB in susceptible populations.</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM India</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM India</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">William J. Clinton Foundation</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">William J. Clinton Foundation</narrative>
  </participating-org>
  <other-identifier ref="3e209ea0-5669-493c-9e4b-2fd619e14ceb" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="IND-T-WJCF" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-11-04" type="1"></activity-date>
  <activity-date iso-date="2020-11-04" type="2"></activity-date>
  <activity-date iso-date="2024-03-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Richard CUNLIFFE</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>richard.cunliffe@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Richard CUNLIFFE</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>richard.cunliffe@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="IN" percentage="100">
   <narrative xml:lang="EN">India</narrative>
  </recipient-country>
  <sector code="12263" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Tuberculosis</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="0E92B28E-6628-4A93-91F4-24A0E3F68B43" percentage="2.26" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Communication Material and Publications (CMP)</narrative>
    </description>
   </budget-item>
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="8.27" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="0.03" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="0.1" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="65.65" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="6.85" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="2C35AA6C-5E80-4406-B78F-58398CFB1668" percentage="0.34" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Living support to client/ target population (LSCTP)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="2.08" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="2F782C08-F342-42A0-ABA7-BD8E9C920F54" percentage="0.2" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Payment for Results</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="14.21" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2021-04-01">2321021</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2021-04-01">2721440</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-04-01">2842174</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2021-04-01">1744274</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2021-04-01">1790799</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2021-04-01">1641746</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2021-04-01">1646901</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2021-04-01">1686978</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2021-04-01">1692315</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2021-04-01">1566797</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2021-04-01">1577500</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2024-01-01"></period-start>
   <period-end iso-date="2024-03-31"></period-end>
   <value currency="USD" value-date="2021-04-01">1220626</value>
  </budget>
  <capital-spend percentage="0.03"></capital-spend>
  <transaction ref="daf07bdd-f330-4ad8-a4e4-4c2229310fa1">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-05-01"></transaction-date>
   <value currency="USD" value-date="2021-05-01">13061442.32</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-WJCF.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">William J. Clinton Foundation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="6ae9e9ca-2e86-42f7-a85d-c1e2e09c72c4">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-07"></transaction-date>
   <value currency="USD" value-date="2021-05-07">2321020</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-WJCF.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">William J. Clinton Foundation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="d25c6e5f-050f-4db7-adc9-fd96d61077d4">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-26"></transaction-date>
   <value currency="USD" value-date="2021-08-26">1699226</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-WJCF.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">William J. Clinton Foundation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a67ed5cd-1996-4c75-9813-f369fcc8f470">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-11"></transaction-date>
   <value currency="USD" value-date="2021-11-11">1870640</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-WJCF.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">William J. Clinton Foundation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="62f1476f-f3b2-4506-a7b9-7898edd4df14">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-02-03"></transaction-date>
   <value currency="USD" value-date="2022-02-03">1124440</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-WJCF.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">William J. Clinton Foundation</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for IND-T-WJCF</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 1561 Denominator: 1908683 Percentage: 81.80</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-04-01"></period-start>
     <period-end iso-date="2021-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1134000 Denominator: 1350000 Percentage: 84.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1859804 Denominator: 2188005 Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2022-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1134000 Denominator: 1350000 Percentage: 84.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2022-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2012400 Denominator: 2340000 Percentage: 86.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-04-01"></period-start>
     <period-end iso-date="2023-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1859804 Denominator: 2188005 Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-10-01"></period-start>
     <period-end iso-date="2024-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2012400 Denominator: 2340000 Percentage: 86.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for IND-T-WJCF</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB incidence rate per 100,000 population</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 199.3</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-04-01"></period-start>
     <period-end iso-date="2021-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 183</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 174</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2022-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 183</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2022-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 164</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-04-01"></period-start>
     <period-end iso-date="2023-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 174</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-10-01"></period-start>
     <period-end iso-date="2024-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 164</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 33.3</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-04-01"></period-start>
     <period-end iso-date="2021-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 30</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 27</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2022-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 30</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2022-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 25</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-04-01"></period-start>
     <period-end iso-date="2023-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 27</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-10-01"></period-start>
     <period-end iso-date="2024-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 25</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for IND-T-WJCF</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified TB cases (all forms) contributed by non-national TB program providers &#x2013; private/non-governmental facilities</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 160745</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 341718 Denominator: 482894 Percentage: 70.77</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
